---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-019892"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2025-07-16T23:59:59+00:00"
generated_at: "2026-05-18T06:15:14.877941+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $15M public offering of 12M units at $1.25/unit

## Summary
- Gross proceeds of $15M before fees; 12,000,000 units sold at $1.25 per unit.
- Each unit comprises one common share (or pre-funded warrant at $0.001) and one warrant exercisable at $1.50 for five years.
- ThinkEquity acted as sole placement agent; cash fee of 7.5% of gross proceeds.
- Net proceeds earmarked for working capital, general corporate purposes, and advancement of business objectives.
- Relies on TSX exemption for interlisted issuers; no Canadian prospectus filed.

## SEC filing metadata
- accession: 0001641172-25-019892
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2025-07-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000164117225019892/0001641172-25-019892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000164117225019892/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-019892
- JSON: https://secwatch.observer/filing/0001641172-25-019892.json
- Plain text: https://secwatch.observer/filing/0001641172-25-019892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.